Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial
Top Cited Papers
- 7 December 2005
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 366 (9502) , 2005-2011
- https://doi.org/10.1016/s0140-6736(05)67760-4
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The current cost of heart failure to the National Health Service in the UKPublished by Wiley ,2012
- Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)European Heart Journal, 2005
- Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMETAmerican Heart Journal, 2005
- Self-care abilities of patients with heart failureHeart & Lung, 2001
- Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high‐risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin‐converting enzyme inhibitor dose at dischargeEuropean Journal of Heart Failure, 2001
- Medication Adherence in Rheumatoid Arthritis Patients: Older Is WiserJournal of the American Geriatrics Society, 1999
- Poor Adherence to Placebo or Amiodarone Therapy Predicts MortalityPsychosomatic Medicine, 1999
- Adherence with Twice-daily Dosing of Inhaled SteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Treatment adherence and risk of death after a myocardial infarctionThe Lancet, 1990
- Precipitating Factors Leading to Decompensation of Heart FailureArchives of internal medicine (1960), 1988